Alerts will be sent to your verified email
Verify Email
CONCORDBIO
|
Concord Biotech
|
Biocon
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Global DMFs filed
|
140.0 . | n/a | n/a |
|
US DMF Filings
|
20.0 . | n/a | n/a |
|
Europe DMF Filings
|
65.0 . | n/a | n/a |
|
Fermentation Capacity
|
1250.0 KL | 125.0 KL | n/a |
|
Total reactor capacity
|
1250.0 kL | n/a | n/a |
|
Japan DMF Filings
|
4.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
2.3 % | 8.0 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
19.73 % | 5.97 % | 34.65 % |
|
5yr average Equity Multiplier
|
1.21 | 2.64 | 1.29 |
|
5yr Average Asset Turnover Ratio
|
0.54 | 0.31 | 0.74 |
|
5yr Avg Net Profit Margin
|
30.4 % | 7.2 % | 35.51 % |
|
Price to Book
|
5.84 | 2.21 | 10.13 |
|
P/E
|
34.17 | 97.96 | 56.04 |
|
5yr Avg Cash Conversion Cycle
|
76.63 Days | -193.26 Days | -112.39 Days |
|
Inventory Days
|
79.03 Days | 102.53 Days | 22.82 Days |
|
Days Receivable
|
132.49 Days | 139.43 Days | 70.51 Days |
|
Days Payable
|
157.9 Days | 307.82 Days | 130.88 Days |
|
5yr Average Interest Coverage Ratio
|
195.92 | 8.77 | 216.76 |
|
5yr Avg ROCE
|
25.76 % | 6.71 % | 45.66 % |
|
5yr Avg Operating Profit Margin
|
43.43 % | 19.38 % | 47.34 % |
|
5 yr average Debt to Equity
|
0.03 | 0.75 | 0.03 |
|
5yr CAGR Net Profit
|
9.62 % | 6.47 % | 10.07 % |
|
5yr Average Return on Assets
|
16.36 % | 2.35 % | 26.69 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.08 % | 54.45 % | 70.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 4.49 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -6.19 % | -4.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
-1.14 % | 9.8 % | 1.14 % |
|
Concord Biotech
|
Biocon
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
Asset Break-Up
|
-
|